mesalamine has been researched along with Amblyopia in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Amblyopia: A nonspecific term referring to impaired vision. Major subcategories include stimulus deprivation-induced amblyopia and toxic amblyopia. Stimulus deprivation-induced amblyopia is a developmental disorder of the visual cortex. A discrepancy between visual information received by the visual cortex from each eye results in abnormal cortical development. STRABISMUS and REFRACTIVE ERRORS may cause this condition. Toxic amblyopia is a disorder of the OPTIC NERVE which is associated with ALCOHOLISM, tobacco SMOKING, and other toxins and as an adverse effect of the use of some medications.
Excerpt | Relevance | Reference |
---|---|---|
"This case of Crohn's disease and uveitis is unusual in that ocular inflammation preceded intestinal involvement, with the atypical feature of chronic intermediate uveitis." | 1.46 | Amblyopia due to intermediate uveitis as the presenting symptom of Crohn's disease in a 6-year-old boy. ( Brazitikos, P; Dermenoudi, M; Mataftsi, A; Matsou, A; Symeonidis, C; Tzetzi, D, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Symeonidis, C | 1 |
Matsou, A | 1 |
Tzetzi, D | 1 |
Dermenoudi, M | 1 |
Brazitikos, P | 1 |
Mataftsi, A | 1 |
1 other study available for mesalamine and Amblyopia
Article | Year |
---|---|
Amblyopia due to intermediate uveitis as the presenting symptom of Crohn's disease in a 6-year-old boy.
Topics: Amblyopia; Child; Crohn Disease; Glucocorticoids; Humans; Male; Mesalamine; Uveitis, Intermediate; V | 2017 |